Opening Possibilities In Glycosylation

The specific sugar patterns on therapeutic proteins, known as glycosylation, are a critical quality attribute according to the FDA. Achieving the correct glycosylation is vital for regulatory approval and the effectiveness of treatments. Traditional production methods often create a difficult balancing act between optimizing protein yield and achieving the desired glycosylation, leading to potential inconsistencies and high costs.

This video explores innovative solutions that uncouple these processes for better outcomes. Watch now to see how you can gain more control over this crucial aspect of drug development.